Key takeaways:
Kesimpta (ofatumumab) is an injectable medication that treats relapsing forms of multiple sclerosis. It offers the convenience of being administered at home rather than a medical office. After three weekly starter doses, Kesimpta is injected once a month.
Kesimpta comes in a 20 mg prefilled syringe or Sensoready Pen. The best medication delivery option for you depends on your preferences. For some people, the Sensoready Pen may be easier to use than the syringe since it injects automatically.
There are ways to save on Kesimpta, which is available as a brand-name medication. The manufacturer offers a free support program where you could access Kesimpta for as little as $0.
If you’re living with relapsing forms of multiple sclerosis (MS), Kesimpta (ofatumumab) is one treatment option your healthcare team may consider prescribing. Kesimpta offers the convenience of being able to administer your doses at home. You can also choose between a prefilled syringe or injector pen, whichever best suits your needs.
When you start Kesimpta, you’ll be given dosing instructions for you or a caregiver to follow. But if you need a refresher on Kesimpta dosages, or have questions about missing your dose, we cover this information and more below.
Kesimpta comes in two forms — a prefilled syringe and a Sensoready Pen. Both products deliver the same Kesimpta dose in the convenience of your own home. You and your healthcare team will decide the best option for you based on your medical history and preferences.
Simple and familiar: Syringes are a familiar injection method for many people. They offer precise control and require minimal assembly.
May require dexterity: Injecting the syringe might be challenging for people with limited hand strength or coordination.
Portable and discreet: Syringes are compact and easily fit in a purse or backpack for on-the-go injections.
Easy and intuitive: The Sensoready Pen clicks and injects automatically when you press it firmly against the skin, removing the need to manually push the plunger.
No visible needle: The needle is inside the Sensoready Pen, where you can’t see it. This may be preferred if needles make you uncomfortable.
Confidence booster: The click-and-inject mechanism provides audible and visual confirmation of a successful injection.
No matter which Kesimpta form you receive, they’re both stored the same way. Prior to use, you should store your Kesimpta injections in the refrigerator (between 36°F to 46°F) in their original container to protect them from light. Don’t place Kesimpta in the freezer or shake it at any point.
If needed, you may store Kesimpta for up to 7 days at room temperature (up to 86°F). If you haven’t used Kesimpta stored this way within the 7 days, return it to the refrigerator. If you don’t use it within another 7 days, throw it away. To help you remember when to use it, write the date you removed Kesimpta from the fridge in the space provided on the box.
Kesimpta prefilled syringes and Sensoready Pens both come in 20 mg doses. You’ll inject Kesimpta more frequently during the first 3 weeks of treatment before you start injecting it once a month.
Week 1: Inject 20 mg dose
Week 2: Inject 20 mg dose
Week 3: Inject 20 mg dose
Week 4: Skip the injection
Week 5 and once monthly thereafter: Inject 20 mg dose
Before injecting Kesimpta, remove it from the fridge about 15 to 30 minutes before your dose. This will help make your injection more comfortable, since cold injections can be more painful. Don’t remove the prefilled syringe needle cover or injection pen cap until you’re ready to use it.
Kesimpta’s once-monthly dosing can make it a convenient option. But, now and again, you may find that you’ve missed a dose. What you should do next depends on whether you missed a weekly starter dose or monthly maintenance dose.
Weekly dose: If you miss a Kesimpta dose in the first 3 weeks of starting the medication, contact your prescriber for when to take your next dose.
Monthly dose: If you miss a once-monthly injection, administer it as soon as possible, even if it's close to your next scheduled dose. The day you inject your missed dose will become your new monthly injection day. Inject your next dose 1 month later. Don’t attempt to double up on doses to make up for doses you’ve missed.
If it’s difficult to stay on track with your Kesimpta injections, it may be helpful to set alarms or use a medication reminder app. Your pharmacist is also a helpful resource for ways to help you administer your medication on time.
Each Kesimpta syringe and injection pen only contain one dose. So, it’s unlikely that you’ll inject too much, unless you double up on doses. But if you accidentally inject too much, you should contact your healthcare team or Poison Control at 1-800-222-1222 for guidance. Based on your situation, they can tell you if you’ll need to take any action.
Kesimpta is a brand-name specialty medication, which means you’ll likely receive it from a specialty pharmacy. The pharmacy staff will typically work with your insurance plan regarding coverage and identify potential savings opportunities for you.
Kesimpta’s manufacturer also offers a free support program called Alongside. If you’re eligible, you may be able to access Kesimpta for as little as $0 through the program.
The typical Kesimpta (ofatumumab) dosage consists of once-weekly injections for the first 3 weeks of treatment, followed by once-monthly injections starting at week 5. Be sure to follow the instructions you’ve been given by your healthcare team. This will help you get the most from treatment and avoid missed doses or injecting too much.
Kesimpta comes as a prefilled syringe and Sensoready Pen. The right form for you depends on your individual needs and preferences. For example, you may find that Sensoready Pens are easier to use.
Always consult your healthcare team for guidance and to address any concerns or questions related to Kesimpta.
Courtney, S. W., et al. (2020). FDA approves Kesimpta® (ofatumumab), the first self-administered B-cell therapy for relapsing forms of MS. Multiple Sclerosis Association of America.
Novartis Pharmaceuticals Corporation. (2024). Kesimpta - ofatumumab injection, solution [package insert]. DailyMed.
Terlizzi, R. D., et al. (2023). Usability validation of the Sensoready® pen in patients with relapsing multiple sclerosis. Therapeutic Delivery.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.